| Followers | 140 |
| Posts | 5783 |
| Boards Moderated | 0 |
| Alias Born | 06/09/2020 |
Saturday, December 27, 2025 5:32:34 AM
And what a great generic image of getting to become an expert.
Had I known that 5 years ago, it could have saved me from thousands of hours of due diligence.
Because we all know, that what NWBO have done in terms of science, research, results, portfolio of patents, automatic manufacturing and scaling, while building the most advanced and licensed cell CDMO in the UK, while licensing the next generation of DC’s for the future, while running combo trials and research for more than a decade with UCLA, plugs straight into a 101 presentation slide for wannabe retailers, while leaving out any arrows and actions that points to
Are we getting manipulated?
Is the share price suppressed?
Would changes to rules, regulations and guidances better our approval prospects?
A new toy maker or a pre-revenue biotech with a successful treatment against all solid tumors being Wall Street manipulated.
Same same. Here is the template to end all templates. The blueprint of wealth!!!!
Start at the arrow and GO … there you have it.
Ohhh I would have been a trillionaire had I just known!!!!
A guy who argued for lawsuits and petitions and were completely wrong about Advent Bioservices and LPs intentions.
Yeah …. that’ll be the day, when I give you any credibility in matters of NWBO.
Merry Christmas and a happy new year.
LONGS 🎄
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM

